E-ISSN 2218-6050 | ISSN 2226-4485
 
2026, Vol: 16, Issue: 3
16 / 3Current Issue ArchiveAims and ScopeAbstracting & IndexingMost Accessed ArticlesMost Downloaded ArticlesMost Cited Articles
Required files to be uploaded

OVJ Manuscript Submissio Form
Title Page
mainarticle_template

Review Article


Recombinant listeriolysin-O as a platform for next-generation vaccines: Mechanisms, immunological evidence, and translational applications in human and veterinary medicine

Thamer J. Shihab, Eman Hashim Yousif.


Abstract
Recombinant Listeriolysin O (rLLO), a cholesterol-dependent cytolysin come from Listeria monocytogenes, has gained increasing attention as a novel immunological adjuvant for next-generation vaccine development. rLLO enhances both innate and adaptive immune responses by facilitating controlled endosomal membrane permeabilization, promoting cytosolic antigen delivery, and enabling efficient antigen cross-presentation, leading to robust CD8⁺ T-cell activation. These immunological properties are particularly advantageous for vaccines targeting intracellular pathogens and malignancies. This narrative review synthesizes current experimental, preclinical, and translational evidence on the application of rLLO across diverse vaccine platforms in human and veterinary medicine, including DNA-, protein-, nanoparticle-, and vector-based formulations. Studies addressing infectious diseases such as tuberculosis, HIV, dengue, and listeriosis, as well as cancer immunotherapy models, are critically examined. Emerging strategies involving fusion proteins, detoxified rLLO mutants, and recombinant delivery systems are highlighted to illustrate advances in formulation design and immunogenic optimization. Despite promising preclinical outcomes, several challenges remain, including the need for comprehensive safety evaluation, optimization of dosing and delivery strategies, and clarification of regulatory pathways. Addressing these limitations through standardized toxicological assessment and large-scale clinical and veterinary trials will be essential for the successful translation of rLLO-based vaccine components. Overall, rLLO represents a versatile and potent immunological tool with significant potential to advance vaccine design in both human and veterinary applications.

Key words: Listeria monocytogenes; Vaccine development; Immune response; CD8+ T cells.


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Thamer J. Shihab
Articles by Eman Hashim Yousif
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Shihab TJ, Yousif EH. Recombinant listeriolysin-O as a platform for next-generation vaccines: Mechanisms, immunological evidence, and translational applications in human and veterinary medicine. Open Vet. J.. 2026; 16(3): 1402-1425. doi:10.5455/OVJ.2026.v16.i3.1

Web Style

Shihab TJ, Yousif EH. Recombinant listeriolysin-O as a platform for next-generation vaccines: Mechanisms, immunological evidence, and translational applications in human and veterinary medicine. https://www.openveterinaryjournal.com/?mno=292418 [Access: April 03, 2026]. doi:10.5455/OVJ.2026.v16.i3.1

AMA (American Medical Association) Style

Shihab TJ, Yousif EH. Recombinant listeriolysin-O as a platform for next-generation vaccines: Mechanisms, immunological evidence, and translational applications in human and veterinary medicine. Open Vet. J.. 2026; 16(3): 1402-1425. doi:10.5455/OVJ.2026.v16.i3.1


Vancouver/ICMJE Style

Shihab TJ, Yousif EH. Recombinant listeriolysin-O as a platform for next-generation vaccines: Mechanisms, immunological evidence, and translational applications in human and veterinary medicine. Open Vet. J.. (2026), [cited April 03, 2026]; 16(3): 1402-1425. doi:10.5455/OVJ.2026.v16.i3.1


Harvard Style

Shihab, T. J. & Yousif, . E. H. (2026) Recombinant listeriolysin-O as a platform for next-generation vaccines: Mechanisms, immunological evidence, and translational applications in human and veterinary medicine. Open Vet. J., 16 (3), 1402-1425. doi:10.5455/OVJ.2026.v16.i3.1


Turabian Style

Shihab, Thamer J., and Eman Hashim Yousif. 2026. Recombinant listeriolysin-O as a platform for next-generation vaccines: Mechanisms, immunological evidence, and translational applications in human and veterinary medicine. Open Veterinary Journal, 16 (3), 1402-1425. doi:10.5455/OVJ.2026.v16.i3.1


Chicago Style

Shihab, Thamer J., and Eman Hashim Yousif. "Recombinant listeriolysin-O as a platform for next-generation vaccines: Mechanisms, immunological evidence, and translational applications in human and veterinary medicine." Open Veterinary Journal 16 (2026), 1402-1425. doi:10.5455/OVJ.2026.v16.i3.1


MLA (The Modern Language Association) Style

Shihab, Thamer J., and Eman Hashim Yousif. "Recombinant listeriolysin-O as a platform for next-generation vaccines: Mechanisms, immunological evidence, and translational applications in human and veterinary medicine." Open Veterinary Journal 16.3 (2026), 1402-1425. Print. doi:10.5455/OVJ.2026.v16.i3.1


APA (American Psychological Association) Style

Shihab, T. J. & Yousif, . E. H. (2026) Recombinant listeriolysin-O as a platform for next-generation vaccines: Mechanisms, immunological evidence, and translational applications in human and veterinary medicine. Open Veterinary Journal, 16 (3), 1402-1425. doi:10.5455/OVJ.2026.v16.i3.1


Author LoginReviewer LoginAbout PublisherOpen Access PolicyEditorial Review PolicyEditorial & Peer Review ProcessPublication Ethics and Publication Malpractice StatementConflict of Interest PolicyPlagiarism PolicyProtection of Research Participants (Statement On Human And Animal Rights)Corrections, Retractions & Expressions of ConcernDigital Archiving & Preservation PoliciesTerms of UseLicense InformationCopyright Information

About Open Veterinary Journal

Open Veterinary Journal provides a fast track coupled with high quality peer review process for original research articles, review articles, short communi ... Read more.



For best results, please use Internet Explorer or Google Chrome.

Contact Information

All correspondence should be addressed to:

Prof. Ibrahim Eldaghayes: Editor-in-Chief

Open Veterinary Journal

Faculty of Veterinary Medicine, University of Tripoli

P.O. Box 13662, Tripoli, Libya

and


Eldaghayes Publisher

www.eldaghayes.com 

Emails: ibrahim.eldaghayes@vetmed.edu.ly

info@eldaghayes.com